Terms of Service · Privacy Policy · Disclaimer
By using this site you agree to our Terms of Service and Disclaimer.
PMHNP Helper
Practice QuestionsCase Library
MedicationsDiagnosesDifferentials
FlashcardsStudy Plan
PricingAbout
Practice QuestionsCase LibraryMedicationsDiagnosesDifferentialsFlashcardsStudy PlanPricingAbout
Questions/Scientific Foundation/Q14 of 51
intermediateopioid receptorsbuprenorphinemethadonepartial agonistprecipitated withdrawal
A 41-year-old woman with opioid use disorder is being transitioned from methadone to buprenorphine. She has been stable on methadone 80 mg daily for two years but requests the switch for scheduling convenience. The PMHNP explains that buprenorphine has a unique receptor profile that differs from methadone. The patient asks why the transition must be carefully timed to avoid precipitated withdrawal.
← PreviousAll Scientific FoundationNext →